对于罕见疾病临床试验的贝叶斯序列决策
Yuan Gao1, Jianling Bai1, Feng Chen1
1Department of Biostatistics, School of Public Heath, Nanjing Medical University, Nanjing, China.
概括
这项研究引入了贝叶斯对罕见疾病临床试验的序列设计. 它允许更早地停止对优越性或徒劳性的试验,节省时间,成本,并防止患者暴露在无效治疗中.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 药物开发 药物开发
背景情况:
- 罕见病临床试验面临重大挑战,包括小患者群体和避免徒劳治疗的伦理需要.
- 传统的固定样本试验设计对于罕见疾病往往是低效的.
- 贝叶斯序列设计提供了一种动态方法,以优化不确定性下的决策.
研究的目的:
- 为罕见疾病的临床试验提出和评估一个新的贝叶斯序列设计框架.
- 根据不断积累的证据,使试验能够更早,更有效地结束.
- 为了减少样本大小,持续时间和成本,同时确保患者安全和可解释的结果.
主要方法:
- 连续贝叶斯因子分析与二进制终点的自适应性停止规则的集成.
- 利用贝叶斯后置概率来确定优势或徒劳的早期终止值.
- 应用贝叶斯因子设计分析以确保试验可行性并指导临时决策.
主要成果:
- 拟议的贝叶斯序列设计为证明有效性 (优越性) 和缺乏有效性 (徒劳性) 的早期试验终止提供了便利.
- 可以大大减少样本规模,试验持续时间和财务支出.
- 患者暴露于缺乏有效性的治疗方法是最小化的,从而提高了伦理试验的进行.
结论:
- 贝叶斯序列设计加快了在罕见疾病中治疗疗效的确认,允许迅速结束试验.
- 这种方法优化了资源配置,并通过避免长时间接触无益疗法来提高患者福利.
- 促进贝叶斯式顺序决策可以加快罕见病药物批准和市场准入.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Study Design in Statistics
9.9K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.9K
Kaplan-Meier Approach
581
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
581
Pharmacokinetic Models: Comparison and Selection Criterion
341
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
341


